Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease (Q51392532)

4 April 2018

title

Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease (English)

1 reference

4 April 2018

author

Jae Hee Cheon

2

1 reference

4 April 2018

author name string

Jae Jun Park

1

1 reference

4 April 2018

Sung Pil Hong

3

1 reference

4 April 2018

Tae Il Kim

4

1 reference

4 April 2018

Won Ho Kim

5

1 reference

4 April 2018

publication date

6 November 2011

1 reference

4 April 2018

Digestive Diseases and Sciences

published in

1 reference

4 April 2018

volume

57

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

133-141

1 reference

4 April 2018

Disease activity courses in a regional cohort of Crohn's disease patients

cites work

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Long-term evolution of disease behavior of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

An update on the epidemiology of inflammatory bowel disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Effects of cigarette smoking on the long-term course of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Immunity, inflammation, and allergy in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

The immune system in the elderly: II. Specific cellular immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

C-reactive protein as a marker for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Review article: biological activity markers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Risk factors for early postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6‐mercaptopurine and azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Thiopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Predicting relapse in Crohn's disease: a biopsychosocial model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-011-1955-9

Patientsʼ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Risk factors for non-adherence to medication in inflammatory bowel disease patients

1 reference

12 December 2020

Classification of inflammatory bowel disease

1 reference

12 December 2020

Optimum duration of treatment with 6-mercaptopurine for Crohn's disease

1 reference

12 December 2020

Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.

1 reference

12 December 2020

Long-term outcome of Crohn's disease following corticosteroid-induced remission

1 reference

12 December 2020

[The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease]

1 reference

12 December 2020

Azathioprine for maintaining remission of Crohn's disease

1 reference

12 December 2020

A simple biological score for predicting low risk of short-term relapse in Crohn's disease

1 reference

12 December 2020

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study

1 reference

12 December 2020

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

1 reference

12 December 2020

The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease

1 reference

12 December 2020

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

1 reference

12 December 2020

Epidemiology of inflammatory bowel disease

1 reference

12 December 2020

Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study

1 reference

12 December 2020

10.1007/S10620-011-1955-9

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018